Monographie - Topotecan - Stabilis 4.0

Ultimele actualizari :
08/05/2024

Citostatic

Topotecan

Injectabil

Stabilitatea in solutie

Stabilitatea in amestec

Factorii care influenteaza stabilitatea

Compatibilitate

Microunde

Bibliografie

Pdf

Formula chimica

Denumirea comerciala

Denumirea comerciala

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Acumil	Mexic
Camtoop	Mexic
Cantop	India
Hycamtin	Arabia Saudita, Australia, Austria, Belgia, Brazilia, Canada, Chilli, Columbia, Danemarca, Ecuador, Egipt, Elvetia, Emiratele Arabe Unite, Finlanda, Franta, Germania, Grecia, Irlanda, Islanda, Italia, Japonia, Luxemburg, Malaezia, Marea Britanie, Norvegia, Olanda, Polonia, Portugalia, Spania, SUA, Suedia, Turcia, Ungaria, Venezuela
Oncotecan	Columbia, Ecuador
Potactasol	Argentina, Belgia, Germania, Norvegia, Romania
Tekan L	Turcia
Topodria	Columbia
Topokebir	Argentina, Peru
Toposec	Peru
Topotecan	Belgia, Canada, Columbia, Germania, Marea Britanie, Norvegia, Peru, Romania, Spania
Topotel	Egipt
Toranex	Mexic
Tpopoxin	Turcia
Viatopin	Ungaria

Bibliografie

Injectabil

Bibliografie : Topotecan

	Tip	Publicare
753	Laborator	Topotecan (Topotecan Hospira®) - Summary of Product Characteristics Hospira 2016
823	Ziar	Patel K, Craig SB, McBride MG, Palepu NR. Microbial inhibitory properties and stability of topotecan hydrochloride injection. Am J Health-Syst Pharm 1998 ; 55: 1584-1587.
1026	Ziar	Mayron D, Gennaro AR. Stability and compatibility of topotecan hydrochloride with selected drugs. Am J Health-Syst Pharm 1999 ; 56: 875-881.
1075	Ziar	Craig SB, Bhatt UH, Patel K. Stability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containers. J Pharm Biomed Anal 1997 ; 16: 199-205.
1274	Ziar	Krämer I, Thiesen J. Pharmazeutische aspekte von topotecan-infusionen. TAP Pharmazeutische Zeitung 1997 ; 31: 30-33.
1423	Ziar	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1425	Ziar	Krämer I, Thiesen J. Stability of topotecan infusion solutions in polyvinylchloride bags and elastomeric portable infusion devices. J Oncol Pharm Practice 1999 ; 5: 75-82.
1662	Ziar	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1953	Ziar	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1976	Ziar	Trissel LA, Xu QA. Physical and chemical stability of palonosetron hydrochloride with topotecan hydrochloride and irinotecan hydrochloride during simulated Y-site administration. Int J Pharm Compound 2005 ; 9, 3: 238-241.

Mentions Légales